National Early Warning Score 2 (NEWS2) to predict poor outcome in hospitalised COVID-19 patients in IndiaResearch Article Published on 2021-12-152022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, [키워드] Admission age ARDS Area baseline Chest conducted COVID-19 death defined help hospitalised hospitalised COVID-19 patient India interquartile range male mechanical ventilation Mortality NEWS2 outcome outcomes oxygen saturation parameter Patient patients with COVID-19 predict predictor Prognosis Prospective Study Pulse rate Result risk stratification SARS-COV-2 infection score sensitivity specificity supplemental oxygen was determined while widespread with COVID-19 X ray [DOI] 10.1371/journal.pone.0261376 PMC 바로가기 [Article Type] Research Article
An Assessment of the Level of COVID-19 Anxiety among Pregnant Women in Poland: A Cross-Sectional StudyArticle Published on 2021-12-142022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Anxiety assessment caused change children conducted consequence COVID-19 COVID-19 pandemic demonstrated diagnostic fear GAD-7 general anxiety disorder-7 (GAD-7) Generalised anxiety disorder Health hospitalised Infection inventory Level material much higher occur Poland Pregnancy pregnant pregnant women Primipara questionnaire Research risk SARS-CoV-2 SARS-COV-2 infection severity severity of COVID-19 short health anxiety inventory (SHAI) significantly significantly higher STAI state-trait anxiety inventory (STAI) statistically the disease women [DOI] 10.3390/jcm10245869 PMC 바로가기 [Article Type] Article
Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort studyCOVID-19 진단을 받은 환자의 입원 후 기능 회복: 종단적 코호트 연구를 위한 프로토콜Multicenter Study Published on 2021-12-132022-09-11 Journal: BMJ Open [Category] SARS, 변종, [키워드] activity acute infection Admission age approved assessment board clinical clinical care conducted COREG COVID-19 COVID-19 illness determinant determinants diagnosed diagnosed with COVID-19 discharge disseminate Effect Epidemiology Ethics Evidence fatigue FIVE frailty functional guidelines Health crisis hospital hospital discharge hospitalisation hospitalised hospitals individual Infection Inpatient International international public health limitation linear longitudinal cohort study Lung function management measure medium minimum multicentre National Older outcome participant Patient peer-reviewed physical platform Primary outcome protocol protocols protocols & registration number registry regression analysis rehabilitation rehabilitation medicine Research Ethics scale Sepsis serious COVID-19 Subgroup analyses subgroup analysis survivor trajectory variants variants of concern website with COVID-19 [DOI] 10.1136/bmjopen-2021-053021 PMC 바로가기 [Article Type] Multicenter Study
Increasing risk of breakthrough COVID-19 in outbreaks with high attack rates in European long-term care facilities, July to October 20212021년 7월부터 10월까지 유럽 장기 요양 시설에서 높은 발병률과 함께 발병 시 획기적인 COVID-19의 위험 증가Rapid Communication Published on 2021-12-092022-09-10 Journal: Eurosurveillance [Category] SARS, 치료기술, [키워드] adjusted relative risk attack rate Care collected data country Coverage COVID-19 COVID-19 case COVID-19 cases COVID-19 outbreak died effective European finding highlight hospitalised Increasing Infection prevention Long-term care long-term care facilities Measures outbreak Outbreaks Prevention and control Relative risk reported risk vaccination Vaccines [DOI] 10.2807/1560-7917.ES.2021.26.49.2101070 PMC 바로가기 [Article Type] Rapid Communication
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19Medicine Published on 2021-12-022022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] activator addition analysed Biomarker blood cell body mass index C-reactive protein (CRP Care Clinical outcome Complication Control correlated COVID-19 COVID-19 disease severity COVID-19 severity creatinine CRP death disease severity efficient enzyme-linked immunosorbent glomerular filtration rate healthcare healthy control Hospital stay hospitalisation hospitalised hospitalised patient ill patient independent individual Infection Kidney injury lactate dehydrogenase LDH Length Length of hospital stay Level males median median age median symptom neutrophil count Neutrophil-to-lymphocyte ratio other variables oxygen Patient patients with COVID-19 patients with SARS-CoV-2 plasma plasminogen predict predictor prognostic prognostic variable recorded reduce renal Respiratory failure risk serum shown significantly higher suPAR urokinase were measured with COVID-19 [DOI] 10.3389/fmed.2021.791716 PMC 바로가기 [Article Type] Medicine
Post-COVID-19 paediatric inflammatory multisystem syndrome: association of ethnicity, key worker and socioeconomic status with risk and severityObservational Study Published on 2021-12-012022-10-05 Journal: Archives of Disease in Childhood [Category] 임상, [키워드] 95% CI Admission adolescent health Asian association Cardiology children Cohort COVID-19 Epidemiology ethnic group Ethnic groups exceeded group groups hospital hospitalised incidence index Inflammatory inotrope intensive care London median Multiple proportions Registered Regression Retrieval retrospective cohort risk SARS-CoV-2 service severity significantly higher South Statistics Ventilation Virology [DOI] 10.1136/archdischild-2020-320388 PMC 바로가기 [Article Type] Observational Study
Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producerCOVID-19 환자의 본국 송환은 신흥 카르바페네마제 생산업체의 수입에 기여했습니다.Case Reports Published on 2021-12-012022-09-11 Journal: Journal of global antimicrobial resistance [Category] SARS, 변종, 치료기술, [키워드] Admission Amino acid analysed Analysis B.1.617.2 Bacteria Bacterial Carbapenemase carried contribute contributed core COVID-19 crisis Delta described detect E. coli Escherichia coli genetic background Genome Germany hospitalised Host IncX3 India indicated isolate Lineage multidrug-resistant Nasopharyngeal swab OXA-48 OXA-484 pandemic Patient patient with COVID-19 Phylogenetic Plasmid producing rectal swab Repatriation reported SARS-CoV-2 SARS-CoV-2 variant sequence sequenced Spread strain Strains Switzerland the patient the SARS-CoV-2 variant VoC whole-genome [DOI] 10.1016/j.jgar.2021.10.012 PMC 바로가기 [Article Type] Case Reports
ARCADIA study protocol: a phase II, randomised, double-blind, placebo-controlled clinical trial to assess the safety and efficacy of AZD1656 in patients with diabetes hospitalised with suspected or confirmed COVID-19ARCADIA 연구 프로토콜: COVID-19가 의심되거나 확인된 당뇨병 환자를 대상으로 AZD1656의 안전성과 효능을 평가하기 위한 2상 무작위 이중 맹검 위약 대조 임상 시험Article Published on 2021-12-012022-09-11 Journal: BMJ Open [Category] SARS, 임상, [키워드] 1:1 affected ARCADIA AZD1656 baseline bioethics case report form caused clinical Clinical and laboratory data Clinical improvement Clinical outcome clinical outcomes clinical trials collected Committee Complication COVID-19 Czech Republic death determine Device diabete diabetes disease severity double-blind East Efficacy Ethical approval Ethics ethics committee EudraCT general diabetes. global pandemic glucokinase Glucose glycaemic control help homeostasis hospital hospitalised Hypothesis immunological immunological mechanism IMPROVE improve clinical outcome improvement increased risk laboratory data Local maintain Medical devices Medicine Medicines Mortality National Health Service Ordinal Scale Patient patients patients with COVID-19 patients with diabete Placebo placebo tablet Placebo tablets placebo-controlled placebo-controlled clinical trial Prague primary endpoint randomised REC receive registration number Romania SARS-CoV-2 SARS-COV-2 infection scale South Sponsor Standard of care survival susceptibility the primary endpoint Trial type 2 diabete type 2 diabetes WHO with COVID-19 [DOI] 10.1136/bmjopen-2021-049650 PMC 바로가기 [Article Type] Article
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort studyBNT162B2 및 Chadox1 NCOV-19 백신 접종 후 COVID-19 병원 입원 및 사망 (EAVE II) : 전향 적 코호트 연구Articles Published on 2021-12-012022-09-06 Journal: The Lancet. Respiratory Medicine [Category] Communicable Disease, COVID-19, Fulltext, SARS, [키워드] (Medical Research Council) 95% CI adjusted Admission Analysis BNT162b2 Care ChAdOx1 ChAdOx1 nCoV-19 challenge clinical factor clinical feature Comorbidities Comorbidity conducted COVID-19 COVID-19 hospitalisation COVID-19 illness COVID-19 mortality COVID-19 test COVID-19 vaccination programme COVID-19 vaccine death died enhanced estimate rate ratio finding first dose FIVE Frequency funding group Health Data Research UK help highest hospital Hospital admission hospitalisation hospitalised incidence individual individuals Industrial Innovation less male management Medical Research Council Mortality National Older age outcome pandemic Pfizer Pfizer–BioNTech platform Poisson regression model primary care prioritised vaccination prospective cohort study Protective rate ratios receiving risk risk of COVID-19 RRs RT-PCR testing SARS-COV-2 infection Scottish severe COVID-19 severe disease Social distancing measure social distancing measures Socioeconomic deprivation Strategy stratified study period Surveillance time-dependent Poisson regression model unvaccinated population unvaccinated populations vaccination Vaccine vaccine dose with COVID-19 [DOI] 10.1016/S2213-2600(21)00380-5 PMC 바로가기 [Article Type] Articles
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial입원한 성인 COVID-19(COV-BARRIER) 치료를 위한 바리시티닙의 효능 및 안전성: 무작위, 이중 맹검, 병행군, 위약 대조 3상 시험Clinical Trial Published on 2021-12-012022-09-11 Journal: The Lancet. Respiratory Medicine [Category] Fulltext, SARS, 임상, 치료법, 치료제, [키워드] 1:1 95% CI Abstract addition all-cause mortality anti-inflammatory properties antivirals Asia assigned available data Baricitinib baseline Care Combination company Corticosteroids country death defined Dexamethasone Disease progression dose double-blind Efficacy and safety enrolled Europe evaluate event exploratory Follow-up French frequencies Frequency hazard ratio High-flow oxygen hospitalised inhibitor intention-to-treat population Invasive mechanical ventilation Janus kinase Japanese Lilly material Mortality non-invasive ventilation North America Odds ratio oxygen parallel-group participant Participants Phase 3 phase 3 trial Placebo placebo group placebo-controlled placebo-controlled trial prevented primary endpoint progressed proportion randomised Randomly receive receiving reduced reduction in Registered Remdesivir risk risk difference safety analyses safety analysis safety population safety profile secondary endpoint selective Serious Adverse Event Serious Adverse Events serious infection serious infections South America Spanish Standard Standard of care study drug systemic corticosteroid systemic corticosteroids the placebo group the primary endpoint thromboembolic translation Treatment two groups venous thromboembolic were assessed with COVID-19 [DOI] 10.1016/S2213-2600(21)00331-3 PMC 바로가기 [Article Type] Clinical Trial